RNA delivery is moving from breakthrough to backbone. This review examines how LNPs and emerging carriers are reshaping scalability, targeting, manufacturing, and real-world deployment of RNA therapeutics.
- In Vivo's Biggest Threat — Comparison To Old Models
- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs
- Conducting A Medical Device Stability Study: A Practical Guide
- Nanotechnology Drug Delivery: A Market Overview
- Combination: The Drug Delivery Word Of The Year For 2026
- In Vivo LNP-Engineered Cytokine-Armored CAR Cells For Solid Tumors
- Electronic Drug Delivery Devices Market: Advancing Smart, Connected Healthcare
- Regulating For Patient Safety And Success With Combination Products
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Self-Injection Of Biologics Made Easy
Ready-to-Use (RTU) 3mL cartridge-based, single-use Pen Devices are specifically designed to ensure consistency of delivery for high-volume, high-viscosity injectable drug delivery systems.
-
De-Risking Visible Particles Through Component Selection
Explore a summary of the FDA’s recent draft guidance “Inspection of Injectable Products for Visible Particulates” and how it applies to components.
-
The Paradigm Shift: From Scale-Up To Scale-Out In Genetic Medicine
The shift from "scale-up" to "scale-out" in genetic medicine enhances production speed, revolutionizing pharmaceutical manufacturing and accelerating life-saving therapies for global patient populations.
-
Gliding Towards De-Risked Combination Product Development
Learn about the critical role plunger stoppers play in determining a combination drug product's exposure to extractables and leachables.
-
Partnering With Clinicians To Improve Pediatric Formulation Development
Greater collaboration between formulation experts and clinical colleagues, including healthcare professionals, is advocated to lead to safe and effective, age-appropriate medicinal products.
-
A Smart, Data-Driven Approach To Formulate Biotherapeutics For PFS
Explore a unique model to predict injection force designed to decorrelate factors linked to formulation development and the ones linked to container and delivery device selection.
-
Data-Driven Innovation Is Drug Delivery's Next Evolution
To mitigate inherent risks like inconsistent dosing, user error, and low adoption due to complex usage procedures, technological innovation in delivery devices is best guided by lessons from the past, including user feedback and follow-on learnings from market data.
-
Quality By Design Principles For Analytical Methods
A QbD approach was used to solve a high-performance liquid chromatography analytical method problem where impurity peaks had shifting retention times, making identification and quantitation problematic.
-
Small-Scale Aseptic Filling Technology Considerations
Small-scale aseptic filling presents a unique set of challenges. Learn what to look for when evaluating small-scale aseptic filling technology.
-
An Insoluble Problem? Oral Drug Solubility With Functional Polymers
Review the basics of solubility enhancement and the formulation and manufacture of products that enhance solubility and common questions on the topic.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
DELIVERED BY DEGRAZIO
-
4 Opportunities For Advancing Drug Delivery
In this article, Fran DeGrazio identifies four prime opportunities for drug delivery developers to move the dial of innovation into 2026 and beyond. These avenues for advancement include diagnostics, patient tolerability, microdosing, and analytical methodologies.

